(SLRX) - Analyzing Salarius Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Salarius Pharmaceuticals (NYSE:SLRX) has seen a significant rise in short interest, with a 215.43% increase since its last report. The company now has 59,000 shares sold short, representing 10.22% of its float. This is higher than the peer group average of 8.53%.
July 30, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Salarius Pharmaceuticals has experienced a 215.43% increase in short interest, now at 10.22% of its float. This is higher than the peer group average of 8.53%.
The significant increase in short interest suggests that market sentiment towards Salarius Pharmaceuticals is bearish. This could lead to downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100